MedTrace Logo

First-in-Man Early Feasibility Study for Transcatheter HOCM Septal Ablation

NCT04770142 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 5

Last updated 2025-04-16

No results posted yet for this study

Summary

Transcatheter Intra-septal RF ablation system (TIRA catheter with its supplemental devices) to treat hypertrophic obstructive cardiomyopathy.

Conditions

  • Hypertrophic Obstructive Cardiomyopathy

Interventions

DEVICE

TIRA catheter

treat hypertrophic obstructive cardiomyopathy

Sponsors & Collaborators

  • Tau-MEDICAL Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Seung-Whan Lee, MD, PhD · Asan Medical Center

Study Design

Allocation
NA
Purpose
DEVICE_FEASIBILITY
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-21
Primary Completion
2024-07-02
Completion
2025-04-08

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04770142 on ClinicalTrials.gov